PETER R. RIEHL;SUNGTACK SAMUEL HAHN;TRIBUTE PHARMACEUTICALS CANADA INC.
发明人:
申请号：
IL23881115
公开号：
IL238811D0
申请日:
2015.05.13
申请国别(地区):
IL
年份:
2015
代理人:
摘要：
Interstitial cystitis and related GAG-deficient conditions of the bladder and urinary tract are treated by instillation of high dose chondroitin sulfate, such as 400mg/20mL. The higher dose of chondroitin is effective for the rapid reduction of symptoms, particularly in patients with severe and otherwise recalcitrant cystitis.
